Literature DB >> 20601148

Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation.

Christian Mahnkopf1, Troy J Badger, Nathan S Burgon, Marcos Daccarett, Thomas S Haslam, Christopher T Badger, Christopher J McGann, Nazem Akoum, Eugene Kholmovski, Rob S Macleod, Nassir F Marrouche.   

Abstract

BACKGROUND: Lone atrial fibrillation (AF) is thought to be a benign type or an early stage of the disease.
OBJECTIVE: This study sought to compare the left atrium (LA) substrate using delayed-enhanced magnetic resonance imaging (DE-MRI) in patients with lone AF versus those with comorbidities.
METHODS: Forty of 333 included patients met criteria for lone AF. All patients underwent DE-MRI to quantify atrial fibrosis as a marker for structural remodeling (SRM) and underwent catheter ablation. Based on the degree of SRM, patients were staged into 4 groups: Utah I (≤5% LA wall enhancement), Utah II (>5% to ≤20%), Utah III (>20% to ≤35%), or Utah IV (>35%).
RESULTS: Distribution in Utah I to IV was comparable in patients with lone AF and non-lone AF. In both groups, a number of patients showed extensive SRM. Mean enhancement (14.08 ± 8.94 vs. 16.94 ± 11.37) was not significantly different between the 2 groups (P = .0721). In the lone AF group, catheter ablation was successful in suppressing AF in all of Utah I, 81.82% of Utah II, 62.5% of Utah III, and none of Utah IV patients. Similar results were achieved in the non-lone AF group. Outcome after ablation was significantly dependent on the SRM of the LA (P < .001).
CONCLUSION: The degree of LA structural remodeling as detected using DE-MRI is independent of AF type and associated comorbidities. Selecting appropriate treatment candidates based on the quality and quantity of atrial fibrosis using DE-MRI would improve procedural outcome and avoid unnecessary intervention.
Copyright © 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601148      PMCID: PMC3106345          DOI: 10.1016/j.hrthm.2010.06.030

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  34 in total

1.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-15       Impact factor: 29.690

2.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

3.  Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators.

Authors:  H C Dittrich; L A Pearce; R W Asinger; R McBride; R Webel; M Zabalgoitia; G D Pennock; R E Safford; R M Rothbart; J L Halperin; R G Hart
Journal:  Am Heart J       Date:  1999-03       Impact factor: 4.749

4.  Diagnosis and characteristics of lone atrial fibrillation.

Authors:  E Davidson; Z Rotenberg; I Weinberger; J Fuchs; J Agmon
Journal:  Chest       Date:  1989-05       Impact factor: 9.410

5.  The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors:  S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

6.  Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury.

Authors:  Nassir F Marrouche; Jens Guenther; Nathan M Segerson; Marcos Daccarett; Harald Rittger; Harald Marschang; Volker Schibgilla; Martin Schmidt; Guido Ritscher; Georg Noelker; Johannes Brachmann
Journal:  J Cardiovasc Electrophysiol       Date:  2007-05-09

7.  Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.

Authors:  Emmanuelle Vermes; Jean-Claude Tardif; Martial G Bourassa; Normand Racine; Sylvie Levesque; Michel White; Peter G Guerra; Anique Ducharme
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

Authors:  Philippe L L'Allier; Anique Ducharme; Pierre-Frédéric Keller; Holly Yu; Marie-Claude Guertin; Jean-Claude Tardif
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.

Authors:  C A Morillo; G J Klein; D L Jones; C M Guiraudon
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

View more
  101 in total

Review 1.  Cardiac magnetic resonance for prediction of arrhythmogenic areas.

Authors:  Esra Gucuk Ipek; Saman Nazarian
Journal:  Trends Cardiovasc Med       Date:  2015-03-03       Impact factor: 6.677

Review 2.  Assessment and impact of cardiac fibrosis on atrial fibrillation.

Authors:  Nazem Akoum; Nassir Marrouche
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  MRI Evaluation of Radiofrequency, Cryothermal, and Laser Left Atrial Lesion Formation in Patients with Atrial Fibrillation.

Authors:  Irfan M Khurram; John N Catanzaro; Stefan Zimmerman; Vadim Zipunnikov; Ronald D Berger; Alan Cheng; Sunil Sinha; Jane Dewire; Joseph Marine; David Spragg; Hiroshi Ashikaga; Henry Halperin; Hugh Calkins; Saman Nazarian
Journal:  Pacing Clin Electrophysiol       Date:  2015-08-17       Impact factor: 1.976

4.  Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

Authors:  Michael A Rosenberg; Marlena Maziarz; Alex Y Tan; Nicole L Glazer; Susan J Zieman; Jorge R Kizer; Joachim H Ix; Luc Djousse; David S Siscovick; Susan R Heckbert; Kenneth J Mukamal
Journal:  Am Heart J       Date:  2014-02-26       Impact factor: 4.749

Review 5.  Bayes Syndrome and Imaging Techniques.

Authors:  Ivan Hernandez-Betancor; Maria Manuela Izquierdo-Gomez; Javier Garcia-Niebla; Ignacio Laynez-Cerdena; Martin Jesus Garcia-Gonzalez; A Barragan-Acea; Jose Luis Irribarren-Sarria; Juan Jose Jimenez-Rivera; Juan Lacalzada-Almeida
Journal:  Curr Cardiol Rev       Date:  2017

Review 6.  Association of Left Atrial Fibrosis Detected by Delayed Enhancement Magnetic Resonance Imaging and Risk of Stroke in Patients with Atrial Fibrillation.

Authors:  Dana C Peters
Journal:  J Atr Fibrillation       Date:  2011-07-15

7.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

8.  Magnetic resonance image intensity ratio, a normalized measure to enable interpatient comparability of left atrial fibrosis.

Authors:  Irfan M Khurram; Roy Beinart; Vadim Zipunnikov; Jane Dewire; Hirad Yarmohammadi; Takeshi Sasaki; David D Spragg; Joseph E Marine; Ronald D Berger; Henry R Halperin; Hugh Calkins; Stefan L Zimmerman; Saman Nazarian
Journal:  Heart Rhythm       Date:  2013-10-03       Impact factor: 6.343

9.  Is Otsu thresholding the answer to reproducible quantification of left atrial scar from late gadolinium-enhancement MRI?

Authors:  Suvai Gunasekaran; Daniel Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2020-09-21

Review 10.  Ablation of long-standing persistent atrial fibrillation.

Authors:  Behram P Mody; Anoshia Raza; Jason Jacobson; Sei Iwai; Daniel Frenkel; Rhadames Rojas; Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.